Last reviewed · How we verify
NCT01721031
DPNB for Prevention of CRDB
Phase 3 trial testing DPNB in Indwelling Urinary Catheter in 58 participants. Completed in 15 December 2015.
1 December 2015
Quick facts
| Lead sponsor | West China Hospital |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 58 |
| Start date | 1 April 2013 |
| Primary completion | 1 December 2015 |
| Estimated completion | 15 December 2015 |
| Sites | 1 location across China |
Drugs / interventions tested
- DPNB
- Tramadol (tramadol) — full drug profile →
Conditions studied
- Indwelling Urinary Catheter — all drugs for Indwelling Urinary Catheter →
- Male Patients — all drugs for Male Patients →
- General Anesthesia — all drugs for General Anesthesia →
Sponsor
West China Hospital
Who can join
Adults 18 to 50, male only, with Indwelling Urinary Catheter or Male Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Catheter-related bladder discomfort (CRBD) secondary to an indwelling urinary catheter is defined as an urge to void or discomfort in the supra-pubic region. This symptom complex may cause patient agitated and exacerbated postoperative pain. In clinic, dorsal penile nerve block (DPNB) was applied for penile surgery including circumcision and some anterior urethra surgery. The investigators hypothesize that DPNB relive CRBD for male patients with indwelling urinary catheter under general anesthesia.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Dorsal Penile Nerve Block With Ropivacaine-Reduced Postoperative Catheter-Related Bladder Discomfort in Male Patients After Emergence of General Anesthesia: A Prospective, Randomized, Controlled Study.
Li JY, Yi ML, Liao R. · · 2016 · cited 15× · PMID 27082620 · DOI 10.1097/md.0000000000003409 -
Dorsal penile nerve block with ropivacaine versus intravenous tramadol for the prevention of catheter-related bladder discomfort: study protocol for a randomized controlled trial.
Li JY, Liao R. · · 2015 · cited 4× · PMID 26715519 · DOI 10.1186/s13063-015-1130-2
Verify or expand the search:
- PubMed search for NCT01721031
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other West China Hospital trials
Trials by the same sponsor.
- NCT07583654 — Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors · Phase 1 · not yet recruiting
- NCT07583914 — Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors · Phase 1 · not yet recruiting
- NCT07492914 — Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma · Phase 2 · recruiting
- NCT07507097 — Study on the Optimal Head Position for Patients With Severe Acute Ischemic Stroke · NA · not yet recruiting
- NCT07472933 — Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01721031 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by West China Hospital
- Last refreshed: 17 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01721031.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing